Harvard Apparatus Regenerative Technology Inc HRGN
$1.52
Last Updated: Aug 20, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
HRGN Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Harvard Apparatus Regenerative Technology Inc is classified as halal.
HALAL
Report Source: undefined Quarter Report
Harvard Apparatus Regenerative Technology Inc. Stock Analysis HRGN
United States Health Care Nano Cap Harvard Apparatus Regenerative Technology, Inc. is a clinical-stage biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. The company is headquartered in Holliston, Massachusetts and currently employs 8 full-time employees. The company went IPO on 2013-10-14. The firm's technology is based on its cell-therapy platform that uses a patient’s own stem cells to regenerate and restore function to damaged organs. The firm is advancing its Cellspan esophageal implant product candidate through an Investigator-Initiated Trial targeting pediatric patients with Esophageal Atresia. Its biocompatible scaffold component of its esophageal implant is constructed primarily of thin polyurethane fibers. Its other product candidates in development pipeline are targeted at the reconstruction of the colon and uterus wound repair. The Company, through its subsidiary, Harvard Apparatus Regenerative Technology Limited, is focused on personal healthcare, including dietary supplements.
Harvard Apparatus Regenerative Technology Inc (HRGN) Chart
Financial Metrics & Statements of Harvard Apparatus Regenerative Technology Inc (HRGN)
FAQ's for Harvard Apparatus Regenerative Technology Inc (HRGN)
- As of August 2026, Harvard Apparatus Regenerative Technology Inc HRGN is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Harvard Apparatus Regenerative Technology Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Harvard Apparatus Regenerative Technology Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Harvard Apparatus Regenerative Technology Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Harvard Apparatus Regenerative Technology Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Harvard Apparatus Regenerative Technology Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Harvard Apparatus Regenerative Technology Inc (HRGN)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
